- Disponible en: http://www.who.int/vaccine_research/diseases/
viral_cancers/en/print.html. Consultado el 21 de marzo, 2006.
- World Health Organization, Department of Vaccines and Other Biologicals, and International Agency for Research on Cancer. The current status of development of prophylactic vaccines against human papillomavirus infection: Report of a technical meeting, Geneva, 16–18 February 1999. Génova, Suiza: Organización Mundial de la Salud: 1999.
- World Health Organization. Report of the consultation on human papillomavirus vaccines. Geneva, Switzerland, April 1005. Disponible en: http://www.who.int/entity/vaccine_research/documents/816%20%20HPV%20meeting%20finalfinalfinalFINALEDIT.pdf. Consultado el 18 de enero, 2006.
- Bosch FX, Manos MM, Muños N, y cols, and the International Biological Study on Cervical Cancer (IBSCC) Study Group. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J natl Cancer Inst. 1995;87:796–802.
- Walboomers JMM, Jacobs MV, Manos MM, y cols. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–19.
- World Health Organization. Sexually transmitted infections increasing—250 million new infections annually. WHO Features [press release]. Diciembre 1990;No.152:1–6.
- Clarke P, Ebel C, Catotti DN, Stewart S. The psychosocial impact of human papillomavirus infection: Implications for health care providers. Int J STD AIDS. 1996;7:197–200.
Lea nuestra